Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Jeffrey DeLong Insider Profile
4 Followers
Mark Jeffrey DeLong, Chief Business & Strat Officer at Apellis Pharmaceuticals, holds 54.69K shares in Apellis Pharmaceuticals (Ticker: APLS). Most recently, Mark Jeffrey DeLong Sold $9,913 shares of Apellis Pharmaceuticals on Mar 19, 2024 for an estimated value of 564.05K.
Mark Jeffrey DeLong Apellis Pharmaceuticals (APLS)Chief Business & Strat Officer
Apellis Pharmaceuticals (APLS)
Chief Business & Strat Officer
Ranked #10,265 out of 98,042 Corporate Insiders
Profitable Transactions
7 out of 8 Profitable Transactions
Average Return
+18.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Mark Jeffrey DeLong's holdings
Insider Roles
Chief Business & Strat Officer
Roles that Mark Jeffrey DeLong holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark Jeffrey DeLong
Mark Jeffrey DeLong's Trading History
List of latest transactions for each holding click on a transaction to see Mark Jeffrey DeLong's performance on stock
You May Also Like
Mark Jeffrey DeLong insider profile FAQ
What is the percentage of profitable transactions made by Mark Jeffrey DeLong?
The percentage of profitable transactions made by Mark Jeffrey DeLong is 88%.
What is the average return per transaction made by Mark Jeffrey DeLong?
The average return per transaction made by Mark Jeffrey DeLong is 18.90%.
What stocks does Mark Jeffrey DeLong hold?
Mark Jeffrey DeLong holds: APLS stocks.
What was Mark Jeffrey DeLong’s latest transaction?
Mark Jeffrey DeLong latest transaction was an Informative Sell of $564.05K.
What was Mark Jeffrey DeLong's most profitable transaction?
Mark Jeffrey DeLong’s most profitable transaction was an Informative Sell of APLS stock on January 23, 2024. The return on the trade was 42.60%.
What is Mark Jeffrey DeLong's role in Apellis Pharmaceuticals?
Mark Jeffrey DeLong's role in Apellis Pharmaceuticals is Chief Business & Strat Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.